Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Follicular Lymphoma Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Follicular Lymphoma Drugsmarket, defines the market attractiveness level of Follicular Lymphoma Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Follicular Lymphoma Drugs industry, describes the types of Follicular Lymphoma Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Follicular Lymphoma Drugs market and the development prospects and opportunities of Follicular Lymphoma Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Follicular Lymphoma Drugs market in Chapter 13.
By Player:
Genentech (Roche)
Jazz Pharmaceuticals
Bayer
Bristol-Myers Squibb
Epizyme
Gilead Sciences
TG Therapeutics
Secura Bio
By Type:
Chemotherapy Drug
Monoclonal Antibody
Kinase Inhibitor
CAR T-cell Therapy
Others
By End-User:
< 55
55-64
65+
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Follicular Lymphoma Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Follicular Lymphoma Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Follicular Lymphoma Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Follicular Lymphoma Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Follicular Lymphoma Drugs Market Analysis and Outlook to 2022
-
7.1 Global Follicular Lymphoma Drugs Consumption (2017-2022)
-
7.2 United States Follicular Lymphoma Drugs Consumption (2017-2022)
-
7.3 Europe Follicular Lymphoma Drugs Consumption (2017-2022)
-
7.4 China Follicular Lymphoma Drugs Consumption (2017-2022)
-
7.5 Japan Follicular Lymphoma Drugs Consumption (2017-2022)
-
7.6 India Follicular Lymphoma Drugs Consumption (2017-2022)
-
7.7 South Korea Follicular Lymphoma Drugs Consumption (2017-2022)
8 Region and Country-wise Follicular Lymphoma Drugs Market Analysis and Outlook to 2028
-
8.1 Global Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
-
8.2 United States Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
-
8.4 China Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
-
8.6 India Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Follicular Lymphoma Drugs Consumption Forecast (2022-2028)
9 Global Follicular Lymphoma Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Follicular Lymphoma Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CAR T-cell Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Follicular Lymphoma Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global < 55 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global 55-64 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global 65+ Consumption and Growth Rate (2017-2022)
10 Global Follicular Lymphoma Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Follicular Lymphoma Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CAR T-cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Follicular Lymphoma Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global < 55 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global 55-64 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global 65+ Consumption Forecast and Growth Rate (2022-2028)
11 Global Follicular Lymphoma Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Follicular Lymphoma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Follicular Lymphoma Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Follicular Lymphoma Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Follicular Lymphoma Drugs Market Competitive Analysis
-
14.1 Genentech (Roche)
-
14.1.1 Genentech (Roche) Company Details
-
14.1.2 Genentech (Roche) Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Genentech (Roche) Follicular Lymphoma Drugs Product and Service
-
14.2 Jazz Pharmaceuticals
-
14.2.1 Jazz Pharmaceuticals Company Details
-
14.2.2 Jazz Pharmaceuticals Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Jazz Pharmaceuticals Follicular Lymphoma Drugs Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Follicular Lymphoma Drugs Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Follicular Lymphoma Drugs Product and Service
-
14.5 Epizyme
-
14.5.1 Epizyme Company Details
-
14.5.2 Epizyme Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Epizyme Follicular Lymphoma Drugs Product and Service
-
14.6 Gilead Sciences
-
14.6.1 Gilead Sciences Company Details
-
14.6.2 Gilead Sciences Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Gilead Sciences Follicular Lymphoma Drugs Product and Service
-
14.7 TG Therapeutics
-
14.7.1 TG Therapeutics Company Details
-
14.7.2 TG Therapeutics Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 TG Therapeutics Follicular Lymphoma Drugs Product and Service
-
14.8 Secura Bio
-
14.8.1 Secura Bio Company Details
-
14.8.2 Secura Bio Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Secura Bio Follicular Lymphoma Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Follicular Lymphoma Drugs
-
Figure Follicular Lymphoma Drugs Picture
-
Table Global Follicular Lymphoma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Follicular Lymphoma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Follicular Lymphoma Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Follicular Lymphoma Drugs Consumption by Country (2017-2022)
-
Figure United States Follicular Lymphoma Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Follicular Lymphoma Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Follicular Lymphoma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Follicular Lymphoma Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Follicular Lymphoma Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Follicular Lymphoma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Follicular Lymphoma Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Follicular Lymphoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Follicular Lymphoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Follicular Lymphoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Follicular Lymphoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Follicular Lymphoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Follicular Lymphoma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Kinase Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global CAR T-cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global < 55 Consumption and Growth Rate (2017-2022)
-
Figure Global 55-64 Consumption and Growth Rate (2017-2022)
-
Figure Global 65+ Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kinase Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAR T-cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global < 55 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 55-64 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 65+ Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Follicular Lymphoma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Follicular Lymphoma Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Genentech (Roche) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Roche) Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Follicular Lymphoma Drugs Product and Service
-
Table Jazz Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Jazz Pharmaceuticals Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jazz Pharmaceuticals Follicular Lymphoma Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Follicular Lymphoma Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Follicular Lymphoma Drugs Product and Service
-
Table Epizyme (Foundation Year, Company Profile and etc.)
-
Table Epizyme Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Epizyme Follicular Lymphoma Drugs Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Follicular Lymphoma Drugs Product and Service
-
Table TG Therapeutics (Foundation Year, Company Profile and etc.)
-
Table TG Therapeutics Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table TG Therapeutics Follicular Lymphoma Drugs Product and Service
-
Table Secura Bio (Foundation Year, Company Profile and etc.)
-
Table Secura Bio Follicular Lymphoma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Secura Bio Follicular Lymphoma Drugs Product and Service
-
